Left Ventricular Size and Ejection Fraction: Are They Still Relevant?


Journal

Heart failure clinics
ISSN: 1551-7136
Titre abrégé: Heart Fail Clin
Pays: United States
ID NLM: 101231934

Informations de publication

Date de publication:
Apr 2019
Historique:
entrez: 6 3 2019
pubmed: 6 3 2019
medline: 20 4 2019
Statut: ppublish

Résumé

Despite the rapid development of emerging imaging technologies, left ventricular ejection fraction represents the cornerstone of diagnosis, choice of treatment, and prognosis in heart failure. However, true myocardial function often remains underestimated or overestimated in different conditions underlying this heterogeneous syndrome. Changes in left ventricular size and left ventricular ejection fraction, termed reverse remodeling, are among the main goals of treatment in heart failure, aimed at halting or attenuating disease progression. The lack of effective therapeutic approaches in nearly one-half of the heart failure population highlights the need for integrating novel echocardiographic measures to better understand the underlying pathophysiologic mechanisms.

Identifiants

pubmed: 30832807
pii: S1551-7136(18)30124-7
doi: 10.1016/j.hfc.2018.12.012
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-158

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Dora Fabijanovic (D)

Department of Cardiovascular Diseases, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb 10000, Croatia.

Davor Milicic (D)

Department of Cardiovascular Diseases, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb 10000, Croatia.

Maja Cikes (M)

Department of Cardiovascular Diseases, University of Zagreb School of Medicine, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb 10000, Croatia. Electronic address: maja.cikes@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH